i






Public Title Status Last Date Modified
26-Week Open-Label Extension Study Evaluating the Safety and Tolerability of Flexible Doses of Oral Ziprasidone in Children and Adolescents with Bipolar I Disorder (Most Recent Episode Manic) . . . Terminated 27 Aug 2020
Effects of Protein Drink A vs Protein Drink B on Testosterone, Anabolic Status, and Metabolic Hormone Profile of Young Men: A Repeated Measures Study . . . Completed 12 Oct 2021
A RANDOMIZED OPEN LABEL PHASE 2B/3 STUDY OF THE SAFETY AND EFFICACY OF NP-120 (IFENPRODIL) FOR THE TREATMENT OF HOSPITALIZED PATIENTS WITH CONFIRMED COVID 19 DISEASE . . . Terminated 19 Jul 2021
A Multicentre, Randomised, Double-blind, Parallel Group, Placebo-controlled, Phase 3 Efficacy and Safety Study of Benralizumab (MEDI-563) Added to Medium to High-dose Inhaled Corticosteroid Plus Long- . . . Ongoing 29 Jun 2020
Dose-finding, efficacy and safety of BI 655064 in patients with active lupus nephritis Completed 04 Mar 2021
A 24-week randomized, open-label Study to evaluate the Safety and Efficacy of Fesoterodine in Subjects aged 6 to 17 Years with Symptoms of Detrusor Overactivity associated with a neurological Conditio . . . Completed 14 Aug 2020
A Retrospective Comparison of Treatment Response between Short Course (6 months) and Extended Course (9 to 12 months) among Filipino Women with Genital Tract Tuberculosis who underwent Medical Managem . . . Completed 07 Jan 2021
Study of Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy in Participants With Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (MK-3475-585/KEYNOTE-585) . . . Completed 22 Jun 2021
Study of Pembrolizumab (MK-3475) Versus Placebo in Participants With Esophageal Carcinoma Who Are Receiving Chemotherapy and Radiation Therapy (MK-3475-975/KEYNOTE-975) . . . Ongoing 17 Sep 2021
A Global, Randomised, Phase 3, Open-label Study of REGN2810 (ANTI-PD 1 Antibody) Versus Platinum Based Chemotherapy in First Line Treatment of Patients With Advanced or Metastatic PD L1+Non-small Cell . . . Ongoing 30 Sep 2020
A non-interventional, prospective 12-months study to characterize the REAL-life effectiveness and treatment patterns of SecukInumab and current standard of care in patient with chronic plaque psoriAsi . . . Completed 19 Mar 2021
A Multi-center, Randomized, Double-blind, Placebo-controlled Phase II/III Clinical Trial to Evaluate the Safety and Immunogenicity of a SARS-CoV-2 Inactivated (Vero Cell) Vaccine in the Elderly 60-80 . . . Ongoing 10 Feb 2021
A Multicenter, Double-Masked, Randomized, Dose-Ranging Trial to Evaluate the Efficacy and Safety of Conbercept Intravitreal Injection in Subjects with Neovascular Age-related Macular Degeneration . . . Terminated 13 Oct 2021
Anti-Coronavirus Therapies to prevent progression of COVID19 (ACT), a randomized trial Ongoing 30 Sep 2020
ASSOCIATION OF IN-PATIENT OUTCOMES AND RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM INHIBITOR USE AMONG HOSPITALIZED HYPERTENSIVE PATIENTS WITH CORONAVIRUS DISEASE 2019 (COVID-19) IN A TERTIARY GOVERNMENT HOS . . . Completed 30 Nov -0001
Characteristics of musculoskeletal signs and symptoms during the recovery phase of moderate to severe COVID-19 patients at the Philippine General Hospital . . . Ongoing 30 Nov -0001
EFFECTIVENESS OF 100% TEA TREE OIL (Melaleuca alternifolia) VERSUS SALICYLIC ACID + LACTIC ACID SOLUTION IN THE TREATMENT OF COMMON WARTS: A RANDOMIZED CONTROL TRIAL . . . Pending 23 Feb 2021
Intravenous Tocilizumab in the Treatment of Patients with Severe and Critical COVID-19-related Pneumonia . . . Ongoing 05 Oct 2020
The Effect in the Acid-base status, Electrolyte levels and Anion-gap following Initial Fluid Resuscitation in Children with Septic Shock with Normal saline, Lactated Ringers and Acetated Isotonic Elec . . . Ongoing 30 Nov -0001
INNOVATE- Inovio INO-4800 Vaccine Trial for Efficacy Ongoing 06 Oct 2021
A 12-Month Open-Label Study to Evaluate the Safety and Tolerability of Pregabalin as Adjunctive Therapy in Pediatric Subjects 1 Month to 16 Years of Age with Partial Onset Seizures and Pediatric and A . . . Completed 17 Jul 2019
A 12-week phase 3, randomized, double-blind, placebo controlled study to evaluate the efficacy and safety of once monthly subcutaneous erenumab 70 mg in adult chronic migraine patients . . . Ongoing 25 Jun 2021
A 12-week randomized, participant-and investigator-blinded, placebo-controlled, parallel group study to explore the efficacy, pharmacodynamics, safety, and pharmacokinetics of two doses of inhaled CSJ . . . Pending 30 Nov -0001
A 12-week, multicenter, randomized, double-blind, parallel-arm, placebo-controlled study to assess the efficacy and safety of CSJ117, when added to existing asthma therapy in patients ≥18 years of a . . . Ongoing 21 May 2021
A 12-week, multicenter, randomized, double-blind, placebo-controlled study to assess the efficacy and safety of QAW039 when added to standard-of-care asthma therapy in patients with uncontrolled asthm . . . Completed 30 Mar 2021
©2022 HERDIN PLUS. All rights reserved. | Contact Us | Keep up to date